Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H20N2S.ClH |
| Molecular Weight | 332.891 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CCC(CN2C3=CC=CC=C3SC4=CC=CC=C24)C1
InChI
InChIKey=IEISBKIVLDXSMZ-UHFFFAOYSA-N
InChI=1S/C18H20N2S.ClH/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20;/h2-9,14H,10-13H2,1H3;1H
| Molecular Formula | C18H20N2S |
| Molecular Weight | 296.43 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB00902Curator's Comment: Description was created based on several sources, including https://www.drugs.com/mmx/methdilazine-hydrochloride.html
Sources: http://www.drugbank.ca/drugs/DB00902
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/mmx/methdilazine-hydrochloride.html
Methdilazine is a phenothiazine compound with antihistaminic activity. Methdilazine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. It is used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Mycobacterium spp. growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/8103345 |
|||
Target ID: CHEMBL231 Sources: http://www.drugbank.ca/drugs/DB00902 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | TACARYL Approved UseUsed in the treatment of pruritus associated with pityriasis rosea. Launch Date1981 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. | 2010-04-08 |
|
| Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice. | 2009-12 |
|
| Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine. | 2005 |
|
| Four simple procedures for the assay of methdilazine in bulk drug and in tablets and syrup using potassium iodate. | 2003-04 |
|
| Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. | 2001-05 |
|
| Altered membrane permeability as the basis of bactericidal action of methdilazine. | 1998-07 |
|
| Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine. | 1993-06 |
|
| Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents. | 1988-07 |
Patents
Sample Use Guides
Usual adult and adolescent dose
Oral, 8 mg every six to twelve hours as needed.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8103345
Methdilazine (Md) could inhibit various Mycobacterium spp. at 5-15 ug/ml concentrations in vitro as well as in vivo.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:51 GMT 2025
by
admin
on
Mon Mar 31 18:22:51 GMT 2025
|
| Record UNII |
T0GSO02UEZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000085950
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
91121
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | RxNorm | ||
|
DBSALT000486
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200959
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
C63950
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
C044642
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
5192
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
T0GSO02UEZ
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
1408000
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
DTXSID3025548
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
SUB03213MIG
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
214-967-3
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
169091
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
14676
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
1229-35-2
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | |||
|
m7306
Created by
admin on Mon Mar 31 18:22:51 GMT 2025 , Edited by admin on Mon Mar 31 18:22:51 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |